Publications
Publications
Bikkasani K*, Qin Q*, Zhong X, Lin J, Galsky M, Oh MK and Tsao CK. Characterizing prostate specific antigen levels at death in patients with metastatic castration resistant prostate cancer: are we underutilizing imaging? Clinical Genitourinary Cancer, 2021. Doi: 10/1016/j.clgc.2021.04. 003.
Zhong X, Cheng B, Wang X and Cheung YK. SMARTAR: An R package for designing and analyzing sequential multiple assignment randomized trials. PeerJ Bioinformatics and Genomics, 2020. Doi: 10.7717/peerj10559
Zhong X and Hao Q. Are women underrepresented in cerebrovascular disease clinical trials? A systematic review of clinical trials in 2002-2017 using the FDA database. MedRixv, 2020. Doi: 10.1101/2020.11.09.20227207
Tharakan S, Zhong X and Galsky M. The impact of globalization of cancer clinical trials on enrollment of black patients. Cancer, 2020
Anish P, Zhong X, Mellgard G, Qin Q, Patel V, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher E and et al. Risk faactors for emergency room and hospital care among patients with solid tumors on immune checkpoint inhibitor therapy. American Journal of Clinical Oncology, 2020
Fredman J, Li L, Kirpalani S, Zhong X, Freeman R, Cheng YT, Alfonso F, McAlpine G, Vakil A, Macon B and et al. Treatment of active delirium for prevention of delirium, novel adaptive of the hospital elder life program. Journal of the American Geriatrics Society, 2020
Zhong X, Lin JY, Li L, Barrett AM, Poeran J and Mazumdar M. Derivation and validation of a novel comorbidity-based delirium risk index to predict postoperative delirium using national administrative healthcare database. Health Service Research, 2020. Doi:10.1111/1475-6773.13565
An-Li Wang, Zhong X and Hurd YL. Comorbidities and sociodemographic determinants in COVID-19 mortality in an US urban healthcare system. MedRxiv, 2020. Doi:10.1101/2020.06.11.20128926
Gibson C, Nia AB, Spriggs SA, DeFrancisco D, Swift A, Perkel C, Zhong X, Mazumdar M, Fernandez N, Patel M, Kim-Schulze S and Hurd YL. Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity. Psychiatry Research, 2020;21. Doi:10.1016/ j.psychres.2020.113380
Patel VG, Zhong X, Liaw B, Tremblay D, Tsao CK, Galsky MD and OH WK. Does androgen deprivation therapy protect against severe complications from COVID-19? Annuals of Oncology, 2020; 31(10): 1419-1420. Doi:10.1016/j.annonc.2020.06.023
Zhong X, Cheng B, Qian M and Cheung YK. Comparing adaptive interventions under a general sequential multiple assignment randomized trial design via multiple comparisons with the best. Journal of Statistical Planning and Inference, 2020; 211: 143-153. Doi:10.1016/j.jspi.2020.06.008
Hao Q, Feldmann E, Balucani C, Zubizarreta N, Zhong X and Levine SR. A new transcranial doppler scoring system for evaluating middle cerebral artery stenosis. Journal of Neuroimaging. 2020; 30 (1):97-103. Doi:10.1111/jon.12678
Zhong X, Cheng B, Qian M and Cheung YK. A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials. Contemporary Clinical Trials. 2019. Doi: 10.1016/j.cct.2019.105830
Zhong X, Mazumdar M, Sharma V, Jandorf L, Welsh D and Marin DB. Predictive model for chaplain taxonomy patterns identified through latent class analysis among infants in a pediatric inpatient setting. Journal of Health Care Chaplain. 2019. Doi:10.1080/08854726.2019.1670537
Sharma V, Marin DB, Zhong X, Mazumdar M, Keogh M, Costello Z and Marin DB. Using the taxonomy: a standard vocabulary of chaplain activities. Journal of Health Care Chaplain. 2019. Doi: 10.1080/08854726.2019.1653636
Nalugoda F, Kreniske P, Hofer S, Zhong X, Wei Y, Santelli John, et al. Cell Phones, Sexual behavior and HIV prevalence in Rakai,nUganda: a cross sectional analysis of longitudinal data. AIDS and Behavior, 2020; 24: 1574-1584
Kalinsky K, Sparano JA, Zhong X, Andreopoulou E, Hershman DL, et al. Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial. Clinical and Translational Oncology, 2018; 20: 1474-1483
Liu YL, Choi C, Lee SM, Zhong X, Hibshoosh H, Kalinsky K and Connolly EP. Invasive lobular breast carcinoma: pleomorphic versus classical subtype. associations and prognosis. Clinical Breast Cancer, 2018; 18(2): 114-120
Neugut AI, Zhong X, Lebwohl B, Hillyer G, Accordino M, Wright JD, Kiran R and Hershman DL. Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study. Therapeutic Advances in Gastroenterology, 2018; 11: 1-10. DOI: 10.1177/1756283X187 65920
Lee SM, Hershman DL, Miao J, Zhong X, Unger JM, and Cheung YK. Estimating global treatment toxicity burden from adverse-event data. Cancer, 2018; 124(4): 858-864
Zhong X. Design and analysis of sequential multiple assignment randomized trial for comparing multiple adaptive interventions. Columbia Academic, 2018; DOI: https://doi.org/ 10.7916/D8DJ6Z1K
Paolo M, Pasquini MC, Atkins H, Botwn J, Farge D, Fassas A, Freedman M, Georges G, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis V, Kozak T, Mancardi G, Massacesi L, Moraes D, Nash R, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnevy M, Zhu L, Badoglio M, Zhong X, Sormani MP and Saccardi R. Long term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurology. 2017; 74(4): 459-469. Doi: 10.1001/jamaneurol.2016.5867
Zhong X, Lin EA, Hershman DL, Moinpour C,M Unger J and Lee SM. Symptom cluster on a advanced prostate cancer. Journal of Oncology Practice. 2016; 12: 270-280. DOI: 10.12.00/JOP.2015.006106
Neugut AI, Zhong X, Wright J, Accordino M, Yang J and Hershman DL. Nonadherence to medication for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncology. 2016; 157(3): 555-564. DOI: 10.1007/s10549-016-3837-5
Liu YL, Saraf A, Lee SM, Zhong X, Hibshoosh H, Kalinsky K and Connolly EP. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 2016; 157(3): 555-564
Chen Q, Zhong X, Acosta L, Divian A, Rundle A, Goldstein IF, Miller RL and Perzanowski MS. Allergic sensitization patterns identified through latent class analysis among NYC asthmatic and non-asthmatic children. Annals of Allergy, Asthma and Immunology. 2016; 116(3): 212-218. DOI: 10.1016/j.anai.2016.01.006
Beksac M, Gargert L, Fingerson S, Maiers M, Zhang M-J, Albrecht M, Zhong X, Cozen W, Dispenzieri A, Lonial S and Hari P. HLA polymorphism and risk of multiple myeloma. Leukemia. 2016; 30(11): 2260-2264. DOI: 10.1038/leu.2016.199
Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jocobson JS, Wright JD and Neugut AI. Psychosocial factors related to Non-persistence with adjuvant endocrine therapy among women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Research and Treatment. 2016; 157(1): 133-143. DOI: 10.1007/s10549-016-3788-x
Cornell RF, Zhong X, ARCE-Lara C, Atallah E, Blust L, Drokyski W, Fenske T, Pasquini M, Rizzo J, Saber W and Hari P. Bortezomib-based induction chemotherapy in transplant ineligible AL amyloidosis improves organ function and leads to transplant eligibility. Bone Marrow Transplant. 2016; 50(7): 914-917. Doi: 10.1038/bmt.2015.73
Mathur S, Wei Y, Zhong X, Song X, Nalugoda F, Lutalo T, Wawer M, Gray R, Serwadda D and Santelli JS. Partner characteristics and HIV acquisitions among youth in Rakai, Uganda. Journal of Adolescent Health. 2015; 69(1): 75-84. DOI: 10.1097/QAI.0000000000000539
Santelli JS, Song X, Holden IK, Wunder K, Zhong X, Wei Y, Mathur S, Lutalo T, Nalugoda F, Gray RH and Serwadda DM. Prevalence of sexual experience and initiation of sexual intercourse among adolescents, Rakai district, Uganda, 1994-2011. Journal of Adolescent Health. 2015; 57(5): 496-505. DOI: 10.1016/j.jadohealth.2015.07.018
Eapen M, Logan B, Horowitz MM, Zhong X, Perales M, Lee SJ, Rocha V, Soiffer RJ and Champlin RE. Bone marrow or peripheral blood progenitor cells for RIC unrelated donor transplantation. Journal of Clinical Oncology. 2015; 33(4): 364-369. DOI: 10.1200/JCO.2014.57.2446
Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird J, Freytes CO, Hale G, Herzig R, Holmberg L, Kamble RT, Kumar S, Lazarus HM, Majhail N, Marks DI, Moreb J, Olsson R, Saber W, Savani B, Schiller GJ, Tay J, Vogl DT, Waller EK Wiernik PH, Wirk B, Lonial S, Krishna A, Dispenzieri A, Brandenburg N, Gale P and Hari P. New cancers after autotransplants for multiple myeloma. Biology of Blood and Marrow Transplantation. 2015; 21(4) 738-745. DOI: 10.1016/j.bbmt.2014.12.028
Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzeri A, Bird J, Freytes C, Gale P, Kindwall-Keller T, Kyle R, Landsburg D, Lazarus H, Munker R, Vivek R, Sharma M, Vogl D, Wirk B and Hari P. Impact of pre-transplant therapy and depth of disease reponse prior to auto transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation. 2014; 21(2): 335-341. DOI: 10.1016/j.bbm t.2014.10.023
Sharma M, Zhang MJ, Zhong X, Abidi M, Dispenzieri A, Freytes C, Gale RP, Kindwall-Keller T, Klumpp T, Mehta P, Mikhael J, Nishihori T, To LB, Vogl D, Akpek G, Gibson J, Holmberg L and Hari P. Older patients with myloema derive similar benefit from autologous transplantation. Biology of Blood and Marrow Transplantation. 2014; 20(11):1896-1903. DOI: 10.1016/j.bbm t.2014.07.013
Alsina M, Becker P, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer E, Vesole D, Logan B, Weisdorf D, Qazilbash M, Popplewell L, McClune B, Bensinger W, Riches M, Giralt S and Pasquini MC. Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biology of Bone and Marrow Transplantation. 2014; 20(8): 1183-1189. DOI: 10. 1016/j.bbmt.2014.04.014
Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V and Gluckman E. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission. Biology of Bone and Marrow Transplantation. 2014; 20(6): 816-822. DOI: 10.1016/j. bbmt.2014.02.2020
Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzeri A, DrobyskiW, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan A, Kyle RA, Marks D, Nishihori T, Pasquini M, Ramanathan M, Lonial S, Saber W, Sharma M, Sorror M, Wirk BM and Hari P. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplant in multiple myeloma. Biology of Blood and Marrow Transplantation. 2014; 20(3): 402-408. Doi: 10.1016/j.bbmt.2013.12.557
Warlick E, Paulson K, Ruta B, Zhong X, Miller AM, Camitta BM, George B, Savani B, Ustun C, Marks D, Wller E, Baron F, Freytes C, Socie G, Akpek G, Schouten HC, Lazarus H, Horwitz EM, Koreth J, Cahn J, Seftel M, Cairo M, Laughlin M, Sabloff M, Ringden O, Gale P, Kamble R, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Leisveld J, Cutle C, Ghobadi A, Uy GL, Eapen M, Weisdorf D and Litzow M. Effect of post remission therapy prior to reduced intensity conditioning allogenerc transplantation for acute myeloid leukemia in first complete remission. Biology of Blood and Marrow. 2014; 20(2): 202-208. DOI: 10.1016/j.bbmt.2013.10.023
Freytes C, Vesole D, LeRademacher J, Zhong X, Gale P, Kyle R, Reece D, Gibson J, Schouten H, McCarthy P, Lonial S, Krishnan A, Dispenzieri A and Hari P. Secondary transplants for multiple myeloma releasing after a prior autotrasplant-reduced intensity allogeneic versus autologous transplantation. Bone Marrow Transplant. 2014; 49(3): 416-421. DOI: 10.1038/bmt.2013.187
Marks D, Woo KA, Zhong X, Appelbaum F, Bachanova V, Barker J, Brunstein CG, Gibson J, Kebriaei P, Lazarus H, Olsson R, Perales M, Pidala J, Savani B, Rocha V and Eapen M. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica. 2014; 99(2): 322-328. DOI: 10.3324/haematol.2013.094193
Cornell R, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske T, Horowitz M, Palmer J, Pasquini M, Rizzo J Saber W, Thomas M and Drobysky W. Divergent effects of Novel immunomodulatory agents and cyclophophamide on the risk of engraftment syndrome after auto peripheral blood stem cell transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2013;19(9): 1368-1373. DOI: 10.1016/j.bbmt.2013.06.017
Michaelis L, Saad A, Zhong X, Le-Rademarcher J, Freytes C, Marks D, Lazarus H, Bird J, Holmberg L, Kamble R, Kumar S, Meehan K, Saber W, Schriber J, Tay J, Vesole D, Dispenzeri A, Krishnan A, Lonial S and Hari P. Outcome of Salvage Second Autologous Transplant for Multiple Myeloma Patients. Biology of Blood and Marrow Transplantation. 2013; 19(5): 760-766. Doi: 10.1016/j. bbmt.2013.01. 004
Costa L, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Anderson K, Gale RP, Wirk B, Savani B, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R and Hari P. Trends in utilization and outcome of autologous transplantation as early therapy for multiple myeloma. Biology of Blood and Marrow Transplantation. 2013; 19(11): 1615-1624. Doi: 10. 1016/j.bbmt.2013.08.002
Pasquini M, Voltarelli J, Atkins H, Hamerschlak N, Zhong X, Woo AK, Sullivan KM Carrum G, Andrey J, Bredeson C, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic S, and Nash RA. Transplantation for autoimmune diseases in North and South America: a report or the Center of International Blood and Marrow Transplant Research. Biology of Blood and
Marrow Transplantation. 2013; 18(10): 1471-1478. Doi: 10.1016 /j.bbmt.2012.06.003
Demond A, Towey T, Adriaens P, Zhong X, Knutson K, Chen Q, Hong B, Gillespie B, Franzblau A, Garabrant D, Lepkowski J, Leksemburg W and Maier M. Relationship between concentrations of PCDDs, PCDFs and dioxin-like PCBs in vegetation and soil on residential properties in two communities in Michigan, USA. Environmental Toxicology and Chemistry. 2010; 29(12):2660-2668. Doi: 10.1002/ect.344